A. Singh, Ankur Kumar, V. Gaur, Indrani Adhikari, Rajesh Singh
{"title":"Recurrence of SARS-CoV-2 RNA among Positive Covid-19 Cases","authors":"A. Singh, Ankur Kumar, V. Gaur, Indrani Adhikari, Rajesh Singh","doi":"10.5799/jmid.951625","DOIUrl":"https://doi.org/10.5799/jmid.951625","url":null,"abstract":"Coronavirus disease 2019 (Covid-19) is a highly infectious disease, and its replication decreasing rapidly after the first week, while some level of immunity is built up. A small proportion of discharged patients may become positive again for severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) RNA, even if they meet the discharge criteria. Re-infection of SARS-CoV-2 is an apparently uncommon entity and only a few case reports or case series have been reported from across the whole world. Herein, we have reported two rare Covid-19 cases with recurrence of positive SARS-CoV-2 RNA after a complete clinical cure. The first case was redetected with Covid-19 with more severity after a gap of approximately three weeks after cure, and the second case has recurred after approximately seven weeks with a complication of pulmonary thromboembolism. We report here, the first few cases of a more vigorous Covid-19 recurrence with SARS-CoV-2 RNA in India. J Microbiol Infect Dis 2021; 11(2):108-114.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73976364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Frequency of Bacteremia due to Carbapenemase-producing Enterobacteriaceae in Pediatric Hematology-Oncology Can Be Reduced by Measures of Hospital Infection Control","authors":"D. Caselli","doi":"10.5799/JMID.897193","DOIUrl":"https://doi.org/10.5799/JMID.897193","url":null,"abstract":"Objectives: The spread of carbapenemase-producing Enterobacteriaceae (CPE) is an emerging problem in children undergoing cancer-directed chemotherapy. A previous Italian survey reported a threefold increase in CPE colonization rate and a fourfold increase of CPE bloodstream infections in a 2 year-observation time interval. Methods: To assess the efficacy of the measures put in place to control this emergency, a second survey was performed in the years 2016-2017 and the results were compared. Results: The overall rate of colonization was comparable between the two study periods: 0.50% (2016-2017) vs. 0.48% (2012-2013). MDR/CPE bacteremia was now reported in 13 children from six centers. The rate of MDR/CPE bacteremia was 0.12 for 1,000 days of hospitalization (95% CI, 0.07-0.21) and compared favorably with that observed in the previous survey (0.42 for 1,000 days of hospitalization; 95% CI, 0.31-0.57; p<0.0001). The strains responsible for bacteremia were Klebsiella pneumonia in 9/13 children, Escherichia coli in 2/13, Citrobacter spp. and Stenotrophomonas maltophilia in one case each. The antibiotic susceptibility was available for 10 MDR/CPE strains. Conclusion: The number of patients colonized by CPE remained stable over the years, while the number of bloodstream infections decreased, as well as the resulting mortality. We conclude that children undergoing chemotherapy are at risk for CPE colonization/infection but the awareness of their colonization status may allow reducing CPE morbidity and mortality. J Microbiol Infect Dis 2021; 11(1):27-31.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"63 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84503931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-Invasive Rhinosinusitis: Clinical and Microbiological Perspective","authors":"D. Sandhu, Veenu Gupta, D. Chhina, M. Munjal","doi":"10.5799/JMID.897184","DOIUrl":"https://doi.org/10.5799/JMID.897184","url":null,"abstract":"Objectives: Objectives: Fungal rhinosinusitis is one of the important healthcare problems and its incidence and prevalence are increasing over the past three decades. It affects approximately 20% of the population at some time in their lives. We aimed to identify and characterize the microorganisms causing non-invasive rhinosinusitis and to correlate the findings with the clinical profile of patients. Methods: Clinically suspected cases of rhinosinusitis were enrolled in the study and detailed clinical history was taken. Samples like nasal mucosa, nasal crusts, scrapings / excised nasal polyps, and biopsy were collected. The specimens were processed for fungal culture. Isolates were identified as per standard protocols. Results: A total of 74 patients clinically suspected of rhinosinusitis were enrolled in our study out of which 60.8% were males. The most common presenting complaint was nasal obstruction (91.8%) followed by nasal discharge (77%). Clinically characterizing, the most common type of non-invasive rhinosinusitis seen in our study was allergic rhinosinusitis (44.6%). KOH positivity was 45.6% and fungal culture positivity was 30.4%. The most common fungal isolate was Aspergillus flavus . Conclusion: and periodic evaluation of the patterns of isolates complications by early institution of appropriate treatment. J Microbiol Infect Dis 2021; 11(1):21-26.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79669194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BK Virus Pneumonia with CMV Colitis in a Kidney Transplant Recipient: Successful Treatment with Non-Cidofovir Based Therapy","authors":"Ali Chaitou, M. Nasser, H. Karnib, Amal Hamieh","doi":"10.5799/JMID.897222","DOIUrl":"https://doi.org/10.5799/JMID.897222","url":null,"abstract":"BK virus (BKV) pneumonia is a rare entity especially seen in immunosuppressed patients, for which cidofovir is the used treatment option. We describe a case of a young female patient who presented for altered kidney function six months following kidney transplantation for focal segmental glomerulosclerosis and was found to have BKV nephritis. Her in-hospital stay was complicated by BKV pneumonia requiring mechanical ventilation, in addition to CMV colitis. She was treated with leflunomide/ciprofloxacin and ganciclovir for her pneumonia and colitis, respectively. The patient improved clinically except that her kidney function deteriorated. Leflunomide/ciprofloxacin combination may constitute an effective and safe alternative to cidofovir for the treatment of BKV pneumonia, in particular when cidofovir is not available. J Microbiol Infect Dis 2021; 11(1):36-41.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84760808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Changing Pattern of Resistance in Typhoid Fever in An Era of Antimicrobial Resistance: Is It Time to Revisit Treatment Strategies?","authors":"S. Saxena, R. Kaur, V. Randhawa","doi":"10.5799/JMID.897134","DOIUrl":"https://doi.org/10.5799/JMID.897134","url":null,"abstract":"Objectives: Multi-drug-resistant Salmonella Typhi is a major concern in the current era of antimicrobial resistance. The emergence of ceftriaxone-resistant Salmonella Typhi strains (CRST) has left very few therapeutic options for the treatment of these infections. The objective of this study was to evaluate the typhoid cases diagnosed with CRST and retrospectively analyze the antimicrobial sensitivity pattern of Salmonella Typhi over the past three years. Methods: Laboratory data from our hospital were reviewed for the past three years to examine the trends related to the isolation of Salmonella Typhi from blood and their antimicrobial susceptibility. The case records from the patients whose blood culture detected Ceftriaxone resistant Salmonella Typhi (CRST) were reviewed to assess the clinical condition and outcome. Results: Analysis of the antimicrobial susceptibility of Salmonella Typhi showed a decline in multidrug-resistant strains. Nalidixic acid resistance has remained high during this period. The resistance to ceftriaxone has shown an increase from 0% in 2016 to 11(12.6%) isolates in 2018. Also, azithromycin resistance has shown a steady increase from 0% in 2016, 3 (3.2%) in 2017 to 7 (8.5%) in 2018. There was no clustering of cases by time or space indicating a non-outbreak spread of ceftriaxone resistant strains. Conclusion: Development of resistance to ceftriaxone and azithromycin necessitates revision of therapeutic choices. All this necessitates an approach to do further extensive surveillance at the community level and improvement in hygiene, sanitation, and drinking water supply. Maybe it is time to revisit the older antibiotics such as ampicillin, cotrimoxazole, and chloramphenicol as therapeutic options for uncomplicated typhoid fever. J Microbiol Infect Dis 2021; 11(1):1-7.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"250 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91533595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Vashisht, R. Gopalakrishnan, S. Nambi, D. Sureshkumar, N. Sethuraman, Yamunadevi Ramanathan, R. Venkatasubramanian
{"title":"Microbial Etiology of Community Acquired Meningoencephalitis In Adults: A Retrospective Review","authors":"R. Vashisht, R. Gopalakrishnan, S. Nambi, D. Sureshkumar, N. Sethuraman, Yamunadevi Ramanathan, R. Venkatasubramanian","doi":"10.5799/JMID.897133","DOIUrl":"https://doi.org/10.5799/JMID.897133","url":null,"abstract":"Objectives: Meningoencephalitis (ME) is a well-recognized clinical entity with diverse infectious etiologies. Only a few studies in the Indian literature are available on this issue, especially in the adult population. The aim is to study the microbial etiology of ME presenting to a tertiary care center. Methods: A total of 97 cases labeled as ME were initially found on review of hospital records in a retrospective review over 5 years. Of these, only 62 were microbiologically confirmed and these were selected for this study. Results: Bacteria were the cause in 21(34%) cases. Pneumococcus was the predominant bacterial etiology, found in 17 cases (detected by PCR in 15 and by culture in 3 cases). Viruses were seen in 13 (21%) cases; Herpes simplex virus (HSV) was seen in 4 cases and enterovirus and varicella in 2 cases each (all were detected by PCR). We also had Arboviruses: Chikungunya (3 cases) and Dengue (2 cases) (serological diagnosis). TB was found in 15 (24%) cases (diagnosed by positive CSF Xpert Mtb in 11 cases and by AFB culture in 7 cases). Cryptococcus was seen in another 13 (21%) cases (detected by positive CSF CRAG in all cases and culture positivity in 7 cases). Conclusion: Pneumococcus and HSV are the commonest agents causing acute ME syndrome. Mycobacterium tuberculosis and Cryptococcus accounted for all cases of chronic ME. Multiplex PCR (in acute ME) and Xpert Mtb and cryptococcal antigen (in chronic ME) play an important role in the diagnosis of culture-negative ME. J Microbiol Infect Dis 2021; 11(1):15-20.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75604361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk of Dengue epidemics in Northern Himalayan state of India: are we prepared enough","authors":"G. Kumar, Shweta Pasi","doi":"10.5799/JMID.897241","DOIUrl":"https://doi.org/10.5799/JMID.897241","url":null,"abstract":"Until recently, Northern Himalayan states like Himachal Pradesh of India were free from the hold of dengue. But a new threat looms with introduction of dengue to comparatively cooler areas of the country. It has been postulated in view of climate change phenomenon that dengue will also become a major public-health threat in Himachal Pradesh in the years to come. Therefore, Assessment of impact of climate change on dengue should be undertaken which will help in quantification of additional burden of the disease and population to be affected at district level. It will also help in early preparedness for coping with the projected effect of climate change on dengue in the vulnerable hot spots. J Microbiol Infect Dis 2021; 11(1):42-43.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83516382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Bouheraoua, F. Assaous, Nora Zourdani, Naima Tahrat, Hassiba Tali Maamar
{"title":"Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria","authors":"S. Bouheraoua, F. Assaous, Nora Zourdani, Naima Tahrat, Hassiba Tali Maamar","doi":"10.5799/jmid.839476","DOIUrl":"https://doi.org/10.5799/jmid.839476","url":null,"abstract":"We describe the emergence of plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19. The strain was isolated from a urine sample of a 75-year-old male patient. The identification was carried out by an automated system. The antibiogram was performed according to CLSI recommendations. The colistin MIC was determined by broth micro-dilution according to CA-SFM/EUCAST criteria. The detection of mcr-1 was carried out by immunochromatographic test and PCR mcr-1. Genetic transfers and determination of the plasmid incompatibility group were made. The ST was carried out by MLST using the Pasteur scheme. The strain has a high-level penicillinase resistance phenotype. It was susceptible to amikacin and resistant to gentamicin, tobramycin, fluoroquinolones, tetracycline, chloramphenicol, and cotrimoxazole. The strain was resistant to colistin (MIC ꞊ 4 μg/ml). The genetic transfer is given a colistin-resistant transconjugant. The plasmid carrying mcr-1 gene belongs to the incompatibility group IncHI2.The strain belongs to ST19. J Microbiol Infect Dis 2019; 10(4):222-224.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76208040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global Analysis of COVID-19 Clinical Related Trials","authors":"M. Rathinasamy, Saritha Kandhasamy","doi":"10.5799/jmid.839379","DOIUrl":"https://doi.org/10.5799/jmid.839379","url":null,"abstract":"Objectives: The aim of this study was to analyze clinical trials using topic modelling to identify emerging vaccine progression topics around the globe. Methods: The most important computational problem for the modeling of topics is using the observed documents to infer the hidden topic structure. The topic model was developed on the basis of data recorded on the WHO International Clinical Trials Registry Platform (ICTRP) between 3 February and 11 August 2020. Results: Show the top 10 topics based on the topic model that has been created. These topics are explored in the reviews and studies of clinical trials related to the development of the COVID-19 vaccine. Conclusion: This study aimed at the clinical trials registered at ICTRP and showed the recorded monthly clinical trials as well as the top 15 countries vying for the COVID-19 vaccine from 3 February to 11 August 2020. Using the dataset of the collected clinical trials, the topic model was developed to examine emerging trends in vaccine progression. J Microbiol Infect Dis 2020; 10(4):xxxxx. Keywords: COVID-19, Clinical trials, Vaccine progression, Emerging topics, Topic model","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77234266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Chaudhari, Rakhi Biswas, C. Meghna, S. Sistla, K. Dharanipragada, B. Krishnan, R. Akhilesh
{"title":"Isolation of Eggerthella lenta from A Cutaneous Abscess Formed at Post-trauma Suture Site","authors":"K. Chaudhari, Rakhi Biswas, C. Meghna, S. Sistla, K. Dharanipragada, B. Krishnan, R. Akhilesh","doi":"10.5799/jmid.839489","DOIUrl":"https://doi.org/10.5799/jmid.839489","url":null,"abstract":"Eggerthella lenta is an emerging pathogen. Its laboratory identification is difficult and hence only limited data is available on its disease spectrum. We report an occurrence of a polymicrobial infection in a cutaneous abscess formed at post-trauma suture site, with rare isolation of this anaerobe, in a healthy immunocompetent man. J Microbiol Infect Dis 2020; 10(4): 230-233.","PeriodicalId":16603,"journal":{"name":"Journal of Microbiology and Infectious Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83022896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}